Has Jonathan Pedrick, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,895 in general payments to Jonathan Pedrick, MD across 218 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Pedrick, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Pedrick, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Pedrick, MD

Physical Medicine & Rehabilitation · Columbus, OHNPI 1235375957

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 40.8% of the total. Reporting peaked in 2022 at $932 and has fallen 79.9% since, to $188 in 2025.

$3,895in general payments, 2019–2025

Across 218 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$563
Collegium Pharmaceutical, Inc.$339
Medtronic$269
Pfizer$226
Biohaven Pharmaceutical Holding Company Ltd.$180
plus $730 from 10 others

What the payments were for

Food & beverage$3,895100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	97	$1,588
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	29	$563
Collegium Pharmaceutical, Inc.	20	$339
Medtronic	2	$269
Pfizer	15	$226
Biohaven Pharmaceutical Holding Company Ltd.	11	$180
Scilex Pharmaceuticals Inc.	11	$151
Abbott	7	$133
Amgen	7	$126
Novartis	6	$96
Biodelivery Sciences International, Inc.	4	$64
Boston Scientific	3	$60
Biohaven Pharmaceuticals, Inc.	2	$39
Vertical Pharmaceuticals, LLC	2	$25
Ipsen Biopharmaceuticals, Inc	1	$20
MDD US Operations, LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTELLIS ADAPTIVESTIM$269

How this compares

$3,895 in reported general payments places this provider in the 85th percentile of 332 physical medicine & rehabilitation providers in Ohio.

See all physical medicine & rehabilitation providers in Ohio →

Medicare billing

Part B allowed, 2024

$74,946

Medicare patients

218

Services billed

5,366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Chlorzoxazone	12	$5,928
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	44	$2,635
Pregabalin	60	$2,551
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	48	$1,644
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	19	$1,635
Oxycodone Hcl	64	$1,298
Armodafinil	11	$899
Gabapentin	55	$434
Propranolol Hcl	41	$428
Methylphenidate Hcl	38	$411
Baclofen	21	$339
Morphine Sulfate	12	$209
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	13	$209
Zolpidem Tartrate	14	$152
Sertraline Hcl	29	$64

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Columbus

Jeffrey StrakowskiColumbus$59K
Caitlin StuberColumbus$33K
Nikhil VermaColumbus$24K
Robert PerkinsColumbus$13K
Albert ClairmontColumbus$2K
Timothy HakeColumbus$2K
Michael BariaLewis Center$175K
Kathryn MosherAkron$121K
Marc OrlandoCincinnati$114K
Aileen PadillaPerrysburg$73K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →